search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
EVALUATING THE IMPACT OF TWO IONOPHORE+NICARBAZIN COCCIDIOSTATS ON INTESTINAL INTEGRITY & PERFORMANCE


Coccidiosis costs global poultry producers more than $4 billion in losses every year.1


Poor Intestinal Integrity caused by


coccidiosis can increase FCR by as much as 0.1 and also negatively impact mortality and body weight.2,3


as high as 0,04€/bird or higher.4


producers can take proactive steps to protect Intestinal Integrity, improve feed effi ciencies and increase weight gains.


Protecting Intestinal Integrity: anticoccidials


Many anticoccidial molecules have been introduced to the global poultry industry as feed additives. Chemical anticoccidials work well for severe challenges, but longer term usage can result in increased resistance. On the other hand, ionophores effectively prevent coccidiosis while also allowing natural immunity to develop.1


About the study: materials and method1


A recent study compared the effectiveness of two ionophores—Monensin and Narasin—in combination with Nicarbazin to control coccidiosis and sought to establish how these two anticoccidials differ in their infl uence on bird performance and gut health.


The trial examined 4,400 Ross broilers challenged with coccidia and evaluated them based on growth performance and the presence of macroscopic lesions on internal organs.


Birds received feed supplemented with either Monensin + Nicarbazin (MN) or Narasin + Nicarbazin (NN) for days 0 to 27, followed by use of Narasin until market weight.


Twenty-fi ve percent of birds in each pen were randomly weighed individually at 27 and 33 days of age. Feed intake per fl oor pen at day 27 and at the end of the study (day 33) were recorded and feed conversion values were computed. Lesion scoring was performed on 66 birds per treatment diet (3 birds/pen).


Results: Intestinal Integrity1


Proportion of birds where coccidiosis gross lesions were observed was reduced by both treatments, Monensin + Nicarbazin and Narasin + Nicarbazin, recording no signifi cant differences.


Elanco and the diagonal bar are trademarks of Elanco or its affi liates.


©2020 Elanco. PM-GLB-MAR-20-0518 (2) Sponsored content by Elanco


Score


Combined costs can be However,


COCCIDIOSIS LESION SCORES* OF BROILERS FED NN OR MN AT 22 D


Monensin + Nicarbazin


Gross Eimeria acervulina (gAC) 066


Gross Eimeria maxima (gMx) 055


Gross Eimeria tenella (gTN) 057


* Scores: 0 = absent, 1 = slight, 2 = severe (n = 66 birds/treatment)


FCR and live BW1


The group treated with Narasin + Nicarbazin demonstrated a signifi cantly lower feed conversion ratio and signifi cantly increased live body weight at days 27 and 33 as compared to the group treated with Monensin + Nicarbazin.


PERFORMANCE OF BROILERS FED NN OR MN AT 27 D Parameter


Monensin + Nicarbazin


Feed conversion ratio


Live body weight (g) a,b


1.566a 1284a


1.458b 1405b


Values with different superscripts are signifi cantly different (P<0.05). n = 550 birds/treatment


PERFORMANCE OF BROILERS FED NN OR MN AT 33 D Parameter


Monensin + Nicarbazin


Cumulative Feed Conversion


Live body weight (g) a,b Carcass quality1


Ready-to-cook weight was signifi cantly improved in the group treated with Narasin + Nicarbazin as compared with the group treated with Monensin + Nicarbazin. Also, the breast weight was signifi cantly improved in the group treated by Narasin + Nicarbazin as compared to the group treated with Monensin + Nicarbazin.


CARCASS YIELD OF BROILERS FED NN OR MN UNTIL 27 D FOLLOWED BY NARASIN UNTIL 33 D


Parameter Live weight (g)


Ready-to-cook (g) Breast weight (g)


a,b


Monensin + Nicarbazin


2032b 1400a 580b


Narasin + Nicarbazin


2159a 1517b 656a


Values with different superscripts are signifi cantly different (P<0.05). n = 110 birds/treatment


1.642a 2026a


1.549b 2178b


Values with different superscripts are signifi cantly different (P<0.05). n = 550 birds/treatment


References: 1


Narasin + Nicarbazin


2 3


Farran MT, Shahib H, Hakeem WG, Kaouk ZM, Harkous AA. Performance of Eimeria challenged male broilers fed two ionophore-Nicarbazin combination. Journal of Applied Poultry Research. 2020; 29:684–691.


Williams R. A compartmentalized model for the estimation of the cost of coccidiosis to the world’s chicken production industry. Int. Journ. for Parasitology. 1999; 29(8).


Brennan J, Bagg R, Barnum D, Wilson J, Dick P. Effi cacy of Narasin in the Prevention of Necrotic Enteritis in Broiler Chickens. Avian Diseases. 2001; 45:210.


4


van der Sluis W. Clostridial enteritis is an often underestimated problem. World Poultry. 2000; 16(7).


Narasin + Nicarbazin


Narasin + Nicarbazin


66 55


18 10 23 1


56 19 10


Key points: Ionophore- Nicarbazin Combinations


Narasin + Nicarbazin signifi cantly improved the performance parameters of Ross 308 broilers challenged with coccidia, namely live body weight at market age and cumulative feed conversion in comparison to Monensin + Nicarbazin.1


Narasin + Nicarbazin improved the carcass quality in comparison to Monensin + Nicarbazin. Ready-to- cook carcass and other carcass parts were signifi cantly improved by Narasin + Nicarbazin in terms of weight and weight percentages.1


When selecting a coccidiostat, Narasin + Nicarbazin is considered a signifi cantly better choice with a greater value to the broiler producer in comparison to MN.1


INTESTINAL INTEGRITY (I2 CORNER


)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124